Lugand Leonard, Mestrallet Guillaume, Laboureur Rebecca, Dumont Clement, Bouhidel Fatiha, Djouadou Malika, Masson-Lecomte Alexandra, Desgrandchamps Francois, Culine Stephane, Carosella Edgardo D, Rouas-Freiss Nathalie, LeMaoult Joel
Hemato-Immunology Research Department, CEA, DRF-Francois Jacob Institute, Saint-Louis Hospital, Paris, France - U976 HIPI Unit, IRSL, Paris University, Paris, France.
Department of Medical Oncology, Saint-Louis Hospital, AP-HP.Nord - Université de Paris, Paris, France.
Front Oncol. 2022 Jul 28;12:898732. doi: 10.3389/fonc.2022.898732. eCollection 2022.
Tumor spheroids play an increasingly important role in cancer research. Their ability to recapitulate crucial features of tumor biology that are lost in the classically used 2D models along with their relative simplicity and handiness have made them the most studied 3D tumor model. Their application as a theranostic tool or as a means to study tumor-host interaction is now well-established in various cancers. However, their use in the field of Renal Cell Carcinoma (RCC) remains very limited. The aim of this work is to present methods to implement a basic RCC spheroid model. These methods cover the steps from RCC tumor dissociation to spheroid infiltration by immune cells. We present a protocol for RCC dissociation using Liberase TM and introduce a culture medium containing Epithelial Growth Factor and Hydrocortisone allowing for faster growth of RCC primary cells. We show that the liquid overlay technique allows for the formation of spheroids from cell lines and from primary cultures. We present a method using morphological criteria to select a homogeneous spheroid population based on a Fiji macro. We then show that spheroids can be infiltrated by PBMCs after activation with OKT3 or IL-15. Finally, we provide an example of application by implementing an immune spheroid killing assay allowing observing increased spheroid destruction after treatment with PD-1 inhibitors. Thus the straightforward methods presented here allow for efficient spheroid formation for a simple RCC 3D model that can be standardized and infused with immune cells to study immunotherapies.
肿瘤球体在癌症研究中发挥着越来越重要的作用。它们能够重现肿瘤生物学的关键特征,而这些特征在传统使用的二维模型中会丢失,再加上其相对简单和便捷,使其成为研究最多的三维肿瘤模型。它们作为一种治疗诊断工具或研究肿瘤与宿主相互作用的手段,目前在各种癌症中已得到广泛应用。然而,它们在肾细胞癌(RCC)领域的应用仍然非常有限。这项工作的目的是介绍实现基本肾细胞癌球体模型的方法。这些方法涵盖了从肾细胞癌肿瘤解离到免疫细胞浸润球体的各个步骤。我们提出了一种使用 Liberase TM 进行肾细胞癌解离的方案,并引入了一种含有表皮生长因子和氢化可的松的培养基,可使肾细胞癌原代细胞生长更快。我们表明,液体覆盖技术可使细胞系和原代培养物形成球体。我们提出了一种基于 Fiji 宏使用形态学标准选择均匀球体群体的方法。然后我们表明,用 OKT3 或 IL-15 激活后,外周血单核细胞(PBMCs)可浸润球体。最后,我们通过实施免疫球体杀伤试验提供了一个应用实例,该试验可观察到用 PD-1 抑制剂治疗后球体破坏增加。因此,这里介绍的简单方法可为一个简单的肾细胞癌三维模型高效形成球体,该模型可以标准化并注入免疫细胞以研究免疫疗法。